Significant heterogeneity in the diagnosis and long-term management of Wilson disease: Results from a large multicenter Spanish study
- 11 November 2022
- journal article
- research article
- Published by Elsevier in Gastroenterología y Hepatología
- Vol. 46 (8) , 577-584
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Wilson's disease: A 2017 updateClinics and Research in Hepatology and Gastroenterology, 2018
- Characteristics and prevalence of Wilson's disease: A 2013 observational population-based study in FranceClinics and Research in Hepatology and Gastroenterology, 2018
- Genetic and environmental modifiers of Wilson disease2017
- Wilson's disease and other neurological copper disordersThe Lancet Neurology, 2015
- D‐penicillamine versus zinc sulfate as first‐line therapy for Wilson's diseaseEuropean Journal of Neurology, 2014
- Efficacy and Safety of Oral Chelators in Treatment of Patients With Wilson DiseaseClinical Gastroenterology and Hepatology, 2013
- Response to different therapeutic approaches in Wilson disease. A long-term follow up studyAnnals of Hepatology, 2012
- EASL Clinical Practice Guidelines: Wilson’s diseaseJournal of Hepatology, 2012
- Zinc Monotherapy Is Not as Effective as Chelating Agents in Treatment of Wilson DiseaseGastroenterology, 2011
- Long‐term follow‐up of Wilson Disease: natural history, treatment, mutations analysis and phenotypic correlationLiver International, 2010